SC
Suvalaxmi Chakraborty
About Suvalaxmi Chakraborty
Data last updated:
Suvalaxmi Chakraborty is a Director at Fortis Healthcare Limited (since 2018), Director at Icici Home Finance Company Limited (since 2025) and Director at Agilus Diagnostics Limited (since 2018), and holds 3 more current directorships. The companies operate in Healthcare, Financial Services and Business Outsourcing. The 6 current companies with reported revenue have a combined latest revenue of ₹11,935 Cr; the largest is Fortis Healthcare Limited at ₹7,850 Cr (FY 2025). Earlier, Suvalaxmi Chakraborty was a Nominee Director at Kaleidofin Private Limited (2020–2025) and Director at Magma General Insurance Limited (2017–2021) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Apr 2018 | 1996 | ₹7,850 Cr (FY 2025) | Active | |
| Director | 13 Apr 2025 | 1999 | ₹2,648 Cr (FY 2024) | Active | |
| Director | 23 Jun 2018 | 1995 | ₹1,432 Cr (FY 2025) | Active | |
| Director | 01 Oct 2024 | 1989 | ₹2.72 Cr (FY 2025) | Active | |
| Managing Director | 12 Apr 2021 | 2020 | ₹1.18 Cr (FY 2024) | Active | |
| Director | 11 Mar 2016 | 2015 | ₹48.7 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Nominee Director | 20 Aug 2020 | 2017 | ₹42.57 Cr (FY 2025) | Active | |
| Director | 21 Jun 2017 | 2009 | Active | ||
| Director | 01 Aug 2018 | 2006 | ₹1,269 Cr (FY 2018) | Active | |
| Director | 25 Mar 2015 | 1991 | ₹104 Cr (FY 2025) | Amalgamated | |
| Nominee Director | 20 Jan 2021 | 2016 | ₹251 Cr (FY 2024) | Active | |
| Nominee Director | 11 Mar 2016 | 2008 | ₹1,525 (FY 2024) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Suvalaxmi Chakraborty
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suvalaxmi Chakraborty
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suvalaxmi Chakraborty
Suvalaxmi Chakraborty currently holds 6 directorships: Fortis Healthcare Limited (Director, since 27 Apr 2018, revenue ₹7,850 Cr (FY 2025)); Icici Home Finance Company Limited (Director, since 13 Apr 2025, revenue ₹2,648 Cr (FY 2024)); Agilus Diagnostics Limited (Director, since 23 Jun 2018, revenue ₹1,432 Cr (FY 2025)); Fortis Malar Hospitals Limited (Director, since 01 Oct 2024, revenue ₹2.72 Cr (FY 2025)); Finreach Solutions Private Limited (Managing Director, since 12 Apr 2021, revenue ₹1.18 Cr (FY 2024)); and 1 more.
Suvalaxmi Chakraborty was first appointed on 25 Mar 2015 as Director at Caspian Impact Investments Private Limited. The most recent appointment on record is 13 Apr 2025 at Icici Home Finance Company Limited.
The 6 current companies of Suvalaxmi Chakraborty that report revenue have a combined latest revenue of ₹11,935 Cr: Fortis Healthcare Limited ₹7,850 Cr (FY 2025); Icici Home Finance Company Limited ₹2,648 Cr (FY 2024); Agilus Diagnostics Limited ₹1,432 Cr (FY 2025); Fortis Malar Hospitals Limited ₹2.72 Cr (FY 2025); Finreach Solutions Private Limited ₹1.18 Cr (FY 2024); and 1 more.
Suvalaxmi Chakraborty held 6 earlier board appointments: Kaleidofin Private Limited (Nominee Director, 20 Aug 2020 to 20 Feb 2025); Magma General Insurance Limited (Director, 21 Jun 2017 to 27 Dec 2021); Iifl Home Finance Limited (Director, 01 Aug 2018 to 15 Jun 2021); Caspian Impact Investments Private Limited (Director, 25 Mar 2015 to 25 Mar 2021); Slice Small Finance Bank Limited (Nominee Director, 20 Jan 2021 to 20 Apr 2021); and 1 more.
The current boards of Suvalaxmi Chakraborty's companies include Ashok Pandit (Fortis Healthcare Limited), Ashutosh Raghuvanshi (Fortis Healthcare Limited), Ashutosh Raghuvanshi (Fortis Healthcare Limited), Dilip Kadambi (Fortis Healthcare Limited), Hsiu Chin Keith Lim (Fortis Healthcare Limited), Indrajit Banerjee (Fortis Healthcare Limited), among others.